SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-003059
Filing Date
2017-04-28
Accepted
2017-04-28 16:20:22
Documents
7
Period of Report
2017-06-20
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2232014zdef14a.htm DEF 14A 707521
2 G348071.JPG g348071.jpg GRAPHIC 16120
3 G181137.JPG g181137.jpg GRAPHIC 5277
4 G1018443.JPG g1018443.jpg GRAPHIC 111411
5 G370364.JPG g370364.jpg GRAPHIC 89090
6 G119982BAI001.GIF g119982bai001.gif GRAPHIC 104504
7 G119982BAI002.GIF g119982bai002.gif GRAPHIC 92466
  Complete submission text file 0001047469-17-003059.txt   1286308
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36306 | Film No.: 17795854
SIC: 2834 Pharmaceutical Preparations